Objective: This study investigated the association between maternal age at birth of last child and likelihood of survival to advanced age.
S everal studies have observed an association between older maternal age and exceptional longevity. Analysis of New England Centenarian Study cohort data revealed that women who gave birth to a child after age 40 years had four times greater odds for being a centenarian compared with women from the same birth cohort who had their last child at a younger age. 1 A study of both Mormon pedigrees (siblings born before 1870) and historical demographic data from Quebec residents (siblings born between 1670 and 1750) documented that women who had their last child at ages between 41 and 44 years and between 42 and 44 years, respectively, had mortality hazard ratios of 0.94 and 0.93 compared with women who gave birth before the ages of 41 and 42 years. 2 For both samples, if the mothers had their last child at age 45 years or older, the hazard ratios were even lower at 0.86 and 0.83, respectively. Analysis of Mormon pedigrees further documented that the brothers and sisters of women who had children at older ages also lived longer. Northernmost Finnish parish registers were used to study the maternal ages of women born between 1679 and 1839, their ages at death, and key covariates such as age at first reproduction, total number of offspring born, mean length of interbirth intervals, and spouse's age at death. Helle et al 3 found that women who had children at the oldest ages also lived the longest, and that every additional year of maternal age translated into a 28% reduction in postreproductive mortality. These studies suggest that women's ability to achieve exceptional longevity and ability to have children at substantially older-than-mean ages have determinants in common and that prolonged fertility may be a marker of slower aging.
The Long Life Family Study (LLFS) is a longitudinal phenotypic and genetic study of 551 families with family members demonstrating clustering for exceptional longevity. The LLFS sample provides an opportunity to further test the association between older maternal age and exceptional survival.
METHODS

Study participants
The LLFS consists of 4,875 participants from 551 families in the United States and Denmark. Enrolled participants belong to one of two generations: the older generation comprising probands and their siblings (G1) and the offspring generation (G2). Spouses in both generations were also enrolled as referent controls. To be eligible for the LLFS, G1 members of a family must have attained old-enough ages to collectively be defined as exceptional based on birth cohortYspecific life tables. Exceptionality was ranked according to a family longevity selection score (FLoSS), which takes into account the percentile rank survival of each sibling in the G1 sibship for all those who survived beyond age 40 years 4 and whether family members were alive to participate in the study. Families with G1 sibships that achieved a FLoSS of at least 7 were asked to enroll in the LLFS. Fewer than 1% of Framingham Heart Study families achieve a FLoSS higher than 7, an indication of the exceptionality of the LLFS sample. Participants have been followed longitudinally since enrollment, which ran from 2006 to 2009 in three locations in the United States (Boston, New York City, and Pittsburgh) and in one location in Denmark. The aim of the LLFS is to identify genetic and phenotypic traits that contribute to survival to extreme ages and subphenotypes of exceptional survival such as measures of healthy aging. Age reporting in the US LLFS sample has been shown to be of high quality. 5 Additional details about the LLFS, such as phenotypic measures, have been well described. 6, 7 
Study design
For this analysis, a nested case-control study was designed to study the association between the age at which a woman had her last child and her age of survival. Therefore, we only included women who bore at least one child. Living and deceased female participants in the LLFS who survived to or beyond the 5th percentile of survival for their birth cohorts (cases) were compared with female participants who died at an age younger than the 5th percentile of survival for their birth cohorts but older than 70 years (controls). Percentiles of survival were determined from birth yearYmatched cohort life tables from the US social security administration. 8 Participants younger than 70 years were excluded to avoid comparing cases and controls from substantially different birth cohorts and, therefore, confounding results caused by differing secular trends. Four hundred fifty-one women from the proband generation (G1) and 11 women from the offspring generation (G2; 970 y) met the inclusion criteria for a total sample of 462 participants. Two G1 participants were excluded because they were younger than 70 years. Ten G1 participants, but none of the G2 participants, were excluded because they were nulliparous. Of the 462 participants, 311 were cases and 151 were controls. Descriptive statistics for these two comparison groups are presented in Table 1 . Histograms of birth year and maternal age at last child birth for cases and controls are provided in the supplemental material (see Fig. S1 , Supplemental Digital Content 1, http://links.lww.com/MENO/A102).
Statistical analyses
Women's characteristics were summarized by median and range for continuous measures and by frequency and proportion for categorical variables (Table 1) . Two Bayesian mixedeffect logistic regression models were used to analyze the association between maternal age at birth of last child and exceptional longevity. 9 In addition to fixed effects, the logit function of both models included a normally distributed random effect with a mean of 0 and a variance following a F distribution to model within-family correlation. The first model included maternal age at birth of last child as a continuous variable ( Table 2 ). Because this model assumed a linear relationship between the log odds for exceptional longevity and maternal age, we also fitted a second model in which maternal age at birth of last child was stratified into four groups (aged e29, 30-32, 33-37, and Q38 y) based on quartiles of maternal age distribution (Table 3 ). Both analyses were adjusted for level of education (G12 vs Q12 y), history of tobacco use (never used vs ever used), parity (1-2 vs Q3 children; to have approximately the same number of 0.61 0.39 to 0.97 Study center (Danish vs US women), parity (Q3 vs 1-2 children), familial longevity (spouses vs blood relatives of the family members selected for longevity), length of education (G12 vs Q12 y), and history of tobacco use (never used vs ever used). Odds ratio (for groups in parentheses) and 95% CIs were estimated using Bayesian mixed-effect logistic models. The Gelman-Rubin statistic was within the range of 0.99 to 1.0001, with three chains indicating convergence of the Markov chain. women in the two groups), and two indicator variables (1) to indicate whether women in the analysis were blood relatives of the family members selected for longevity (as opposed to the spouses, who were not selected for familial longevity) and (2) to indicate whether the women were members of families enrolled in Denmark rather than in the United States. All parameters were assigned normal prior distributions with a mean of 0 and a prior variance of 100; the family-specific random effect was also assigned a normal distribution. Gibbs sampling was used to generate samples of at least 50,000 values (after an initial burn-in of 2,000 iterations) from the marginal distribution of the parameters of the logistic regression models and odds ratios (ORs). The Gelman-Rubin statistic was used to verify the convergence of the method. Sample medians and percentiles (2.5 and 97.5) were used to determine point estimates and 95% credible intervals of the parameters (Tables 2, 3 ). Statistically significant associations were determined by 95% credible intervals not including 0 (corresponding to an OR different from 1). Interaction between parity and maternal age at birth of last child was tested but did not reach statistical significance. Statistical analyses were conducted using the Openbugs software package (http:// www.openbugs.info/w/). Representative scripts used for analysis are available in the supplemental material. The robustness of the results of prior assumptions was examined by repeating the analyses for different prior distributions (see Supplemental Tables 1 and 2 Table 1 shows the summary statistics for the study participants. Compared with cases, controls were more likely to have a history of smoking, higher education, and lower frequency of familial longevity. The median maternal age at birth of last child was 34 years for both cases and controls. The two groups had equal proportions of women enrolled in Denmark and the United States and comparable proportions of women having three or more children. Table 2 shows the increase in the odds for exceptional longevity for every 1-year increase in maternal age at birth of last child. Each additional year of maternal age is associated with a 5% increase in the odds for exceptional longevity, after controlling for covariates. This effect is much smaller than the effect of familial longevity on a woman's odds for exceptional longevity (OR, 5.18). For example, in comparing two women with the same level of education, smoking history, study site, and parity, an equivalent increase in the odds for exceptional longevity attributable to familial longevity would need an unrealistic 33-year difference in maternal age at last child birth. Thus, familial longevity is a much stronger predictor of longevity than maternal age at birth of last child. The estimated effect of maternal age at last child birth did not change substantially when the indicator variable for familial longevity was dropped from the model (see Supplemental Tables 5 and 6 , Supplemental Digital Content 2, http://links.lww.com/MENO/A103).
RESULTS
We observed that having more children (eg, Q3 children) tempered the association between increased maternal age and later survival. For example, about a 5-year increase in maternal age at last child birth for women with one to two children increased the OR for exceptional survival by 1.29 (black line in Fig.) , whereas an equivalent increase in the OR for women with three or more children required a difference in maternal age at last child birth of about 16 years (red line in Fig.) . Although the interaction between parity and maternal age at last child birth did not reach statistical significance (log(OR), j0.04; 95% CI, j0.13 to 0.04), a negative parameter suggests that increased parity (defined as Q3 children) decreases the effect of older maternal age at birth of last child on longevity.
To explore whether the assumption of a log-linear association between maternal age at last child birth and odds for exceptional longevity is correct, we also conducted an analysis 0.61 0.39 to 0.97 Maternal age at last child birth was stratified by quartiles. Study center (Danish vs US women), parity (Q3 vs 1-2 children), familial longevity (spouses vs blood relatives of the family members selected for longevity), length of education (G12 vs Q12 y), and history of tobacco use (never used vs ever used). Odds ratio (for groups in parentheses) and 95% CIs were estimated using Bayesian mixed-effect logistic models. The Gelman-Rubin statistic was within the range of 0.99 to 1.0001, with three chains indicating convergence of the Markov chain.
FIG. The increasing trend of the two lines shows a positive association between maternal age at last child birth and exceptional longevity. The downward shift of the lines for increasing parity shows the negative effect of parity on the odds for exceptional longevity. For example, although an approximately 14-year difference in maternal age at last child birth increases the odds for exceptional longevity by two in women with one or two children, the same effect on women with three or more children would require a 24-year difference. OR, odds ratio. in which maternal age at last child birth was stratified into quartiles. Results of the multivariate logistic regression analysis are summarized in Table 3 and show a significant association between older maternal age and exceptional survival: women who had their last child when they were aged 33 to 37 years had twice the odds for living past the 5th percentile of survival for their birth cohort than women who had their last child before age 29 years (OR, 2.08; 95% CI, 1.13 to 3.92). The odds were slightly lower for maternal age of 38 years or older (OR, 1.92; 95% CI, 1.02 to 3.68) but were not significantly different from the age group 33 to 37 years (the small number of women achieving these oldest maternal ages could have influenced the statistical significance). Maternal age at last child birth between 29 and 33 years also slightly increased the odds for longevity compared with women who had their last child before age 29 years, but this association did not reach statistical significance (OR, 1.31; 95% CI, 0.71 to 2.44).
Sensitivity analysis (summarized in Tables 1-4, Supplemental Digital Content 2, http://links.lww.com/MENO/A103) showed that the results are robust to varying prior distributions for the parameters.
DISCUSSION
Among female LLFS participants, older maternal age at last child birth was a predictor of survival past the oldest 5th percentile of their respective birth cohorts. For each additional year in maternal age at last child birth, the odds for exceptional longevity increased by 5%. Women who had their last child at age older than 33 years had twice the odds for exceptional survival than women who had their last child before age 29 years. Although significant, the relatively wide CIs for this finding suggest that we would do well to repeat this study when we have more observations (eg, the LLFS will accumulate more controls as participants pass away and we definitively realize their ages of survival). These findings are, at the least, consistent with other studies of the relationship between maternal age at birth of last child and exceptional longevity. 1, 2, 10 The positive association between older maternal age and the odds for exceptional longevity remains significant even after adjusting for familial longevity.
Twin studies have noted that about 20% of the variation in survival to the mid 80s is probably genetic and that the remaining 80% is attributable to variation in environmental and behavior-related exposures. 11, 12 The findings from these studies are consistent with the findings from the Seventh Day Adventist Health Study, which concluded that most people should be able to survive to their mid to late 80s if they engage in healthy behaviors such as daily exercise, no tobacco or alcohol use, vegetarian diet, and stress management (eg, by engaging in family and religious activities). 13 Several studies have also established that the influence of genetic variation increases the chances of surviving beyond the age of approximately 90 years and becomes stronger the more exceptional or rare is the age of survival. For example, Tan et al 14 noted that the power to discover genetic variants associated with exceptional longevity is significantly increased when the sample consists of centenarians rather than nonagenarians. Furthermore, several studies have shown that a sibling's relative risk of surviving to extreme old age increases from negligible (if the proband survived to his/her 80s) to significant (if the proband survived to his/her mid to late 90s). 15<20 These risks become even greater if the proband is about 102 years old, in which case the probability of surviving to 100 years relative to 1900 birth cohortYspecific mean survival rates becomes 8 times greater for female siblings and 17 times greater for male siblings. 21 That this survival advantage is likely to have a genetic component is suggested by the results from the New England Centenarian Study. The New England Centenarian Study discovered genetic profiles, based on a set of 281 single nucleotide polymorphisms, that can accurately differentiate between centenarians and general population controls. 22, 23 Although the accuracy of this differentiation is about 60% for participants who are 100 years old, it increases to 85% for centenarians aged 106 years or older. This increased accuracy is consistent with the increasing relative influence of genetic variation on survival with increasing age beyond age 90 years.
These findings raise the question of what might be the evolutionary mechanism or selective pressure that selects for genetic variants that facilitate survival long after the age at which reproduction ceases. Perls and Fretts 24, 25 previously proposed that a selection pressure for longevity-associated genetic variants could be the pressure to facilitate a longer period during which women can bear children and therefore have more of them. This theory is consistent with the disposable soma theory, which asserts that there is a tradeoff in energy allocation between reproductive fitness and repair/ maintenance functions. 26, 27 Women who age more slowly and avoid age-related diseases that adversely affect fertility (and therefore live to much older ages) have biological mechanisms that enhance the efficiency of energy production, thus facilitating the delay in this tradeoff. According to the grandparent hypothesis, mechanisms that would facilitate living to old-enough ages to be a grandparent would allow grandparents or even older generations to care for their descendants while the parents carried out more labor-intensive activities to ensure their children's survival. 28, 29 Given that increased parity could be one of the benefits of longevity-associated genetic variants, we investigated the relationship with higher parity, which we defined as having three or more children. Fifty-two percent of the women in the top 5th percentile of survival versus 58% of controls had three or more children. Our findings are consistent with those of the Rotterdam Study, which noted significantly lower mortality for women who had two to three children than for women who had no children or had more than three children. 30 Assessing the relationship between parity and exceptional longevity among long-lived individuals who were alive in recent history might not be germane to the conditions in prehistoric times when longevity-associated genes evolved. There are probably very different competing and influencing factors between these two periods. Unlike the Rotterdam Study, we did not assess relative mortality for women who had no children. Nulliparous women were excluded from this study sample because they were not informative for our estimate of ages at which women were not reproductively senescent. It is notable, however, that only 70 women in the entire LLFS sample never had children. This is not surprising given that the LLFS cohort is generally exceptionally healthy. One hypothesis would be that women who had no children had diseases or environmental exposures that impaired fertility and decreased survival (eg, diabetes, hypertension, and autoimmune disorders). Many of these 68 women are currently alive and younger than 70 years; thus, we are unable to assess mortality risk associated with nulliparity in the LLFS.
We note some potential limitations to this study. Because we limited controls to only those who had died (so that we could be certain of their life spans), as we lowered the age of survival, the number of controls that we could include dropped dramatically. For example, when we used the 10th percentile of survival, we were able to include only a quarter of the deceased women. Thus, the top 5th percentile was used as cutoff. We performed a sensitivity analysis to determine whether changing the percentile of survival for the control group affected our results. Selecting cases that were even older, such as at least 100 years old, still led to similar results (see Supplemental Tables 3 and 4 , Supplemental Digital Content 2, http://links.lww.com/MENO/A103). An alternative analysis that removes the definition of cases and controls could use survival to age at death as a response variable. However, the LLFS still has limited follow-up (mean follow-up, 5 y) and most individuals are still alive; thus, the power of this analysis would be limited. Also, differences in birth cohorts between cases and controls could be a confounder. However, known longevity-associated factors, such as length of education, health care, and socioeconomic status, would have improved (though slightly) in controls who were born later than the cases. This possible enhanced risk for survival in controls would bias against our hypothesis of older survival for cases; therefore, these demographic trends would strengthen our findings. Another important limitation that we must consider are the relatively few factors (eg, education and tobacco use) that we controlled for in assessing the relationship between maternal age at last child birth and survival. However, factors that predispose to age-related diseases and accelerated aging probably also influence reproductive senescence; for this reason, we regard the age of such senescence as a marker or predictor of ultimate survival. Still, for future studies, a more comprehensive accounting of factors known to influence survival to extreme old age would be helpful.
CONCLUSIONS
Numerous studies have observed the relationship between older maternal age at birth and exceptional survival, thus providing evidence for sustained reproductive fitness, with age as a selective force for genetic variants conducive to longer life. These findings support the conduct of studies of the genetic influences of reproductive fitness, which may also influence rate of aging and susceptibility to age-related diseases. 31, 32 
